Get the Stockscreener App
1.33
1.48%
-0.02
After Hours:
1.35
0.02
+1.50%
Alector Inc stock is traded at $1.33, with a volume of 569.03K.
It is down -1.48% in the last 24 hours and down -11.33% over the past month.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
See More
Previous Close:
$1.35
Open:
$1.36
24h Volume:
569.03K
Relative Volume:
0.22
Market Cap:
$145.17M
Revenue:
$100.56M
Net Income/Loss:
$-119.05M
P/E Ratio:
-1.0813
EPS:
-1.23
Net Cash Flow:
$-231.16M
1W Performance:
+7.26%
1M Performance:
-11.33%
6M Performance:
-6.34%
1Y Performance:
-47.74%
1-Day Range:
$1.30
$1.36
1-Week Range:
$1.26
$1.39
52-Week Range:
$0.87
$3.3999
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.33 | 147.35M | 100.56M | -119.05M | -231.16M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-22-25 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-22-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-22-25 | Downgrade | Mizuho | Outperform → Neutral |
| Oct-22-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-28-25 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-17-24 | Downgrade | Mizuho | Outperform → Neutral |
| Dec-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-29-24 | Reiterated | H.C. Wainwright | Buy |
| Nov-26-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-23 | Upgrade | Stifel | Hold → Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Sep-25-23 | Initiated | Goldman | Sell |
| Sep-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
Will Alector Inc. stock outperform tech sector in 2025Quarterly Profit Summary & Consistent Income Trade Ideas - moha.gov.vn
How rising interest rates impact Alector Inc. stockRate Cut & AI Optimized Trade Strategies - moha.gov.vn
Alector, Inc. (ALEC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Alector, Inc. (ALEC) Investors to Inquire about Securities Investigation - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Alector, Inc. (ALEC) And Encourages Investors to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Alector, Inc. (ALEC) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm - Caledonian Record
Bronstein, Gewirtz & Grossman, LLC Is Investigating Alector, Inc. (ALEC) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Alector, Inc. (ALEC) And Encourages Shareholders to Reach Out - ACCESS Newswire
Alector Inc (ALEC) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Bronstein, Gewirtz & Grossman, LLC Encourages Alector, Inc. (ALEC) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Is Alector Inc a good long term investmentSwing Trading Watchlist & Big Gains Small Trading - earlytimes.in
How Analysts See Alector’s Story Shifting After the Latest Clinical Setback - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Alector, Inc. (ALEC) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Alector, Inc. (ALEC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Why Alector Inc. stock is in analyst buy zoneJuly 2025 Spike Watch & Expert Approved Momentum Trade Ideas - newser.com
What Wall Street predicts for Alector Inc. stock priceJuly 2025 Final Week & Proven Capital Preservation Tips - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Alector, Inc. (ALEC) And Encourages Stockholders to Reach Out - ACCESS Newswire
Is Alector Inc. (0Z2) stock a safe buy pre earnings2025 Buyback Activity & Long Hold Capital Preservation Tips - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Alector, Inc. (ALEC) And Encourages Investors to Connect - ACCESS Newswire
Is Alector Inc. stock attractive after correctionJuly 2025 Earnings & Risk Adjusted Buy and Sell Alerts - newser.com
Why Alector Inc. (0Z2) stock is a strong buy callMarket Movement Recap & Pattern Based Trade Signal System - newser.com
Why Alector Inc. stock remains a top recommendationQuarterly Profit Report & Reliable Intraday Trade Alerts - newser.com
Why Alector Inc. stock remains undervaluedEarnings Summary Report & Verified High Yield Trade Plans - newser.com
Is Alector Inc. stock attractive for growth ETFsJuly 2025 Chart Watch & Free Technical Pattern Based Buy Signals - newser.com
Full technical analysis of Alector Inc. stock2025 Market Overview & Technical Pattern Based Signals - newser.com
Is Alector Inc. (0Z2) stock supported by strong fundamentalsWeekly Risk Report & Community Consensus Picks - newser.com
Developing predictive dashboards with Alector Inc. dataTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com
Alector Stock Plummets 63% in a Month: Here's What You Need to Know - Finviz
Did You Suffer Losses in Alector, Inc. (ALEC)? Contact Levi & Korsinsky About Securities Fraud Claims - ACCESS Newswire
Morgan Stanley cuts Alector stock price target to $0.75 on model updates - Investing.com Canada
Alector Inc (ALEC) can make a big difference with a little luck - Setenews
Alector price target lowered to 75c from $1.50 at Morgan Stanley - TipRanks
Alector Inc. (ALEC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):